The weight loss company NOOM is pivoted with a small amount of WEGOVY.
AMINA NIASSE New York (Reuters) -The online weight loss company NOOM has begun providing a combination of a small amount of WEGOVY for a small amount of Novo Nordisk for mass production of on-demand pharmaceuticals. NOOM will provide a composite semi -glue tide version, an active ingredient of Wegovy and Diabetes Drug Ozempic as part of a personalized program for patients. The next -generation…














